Cite
Morishita KA, Wagner-Weiner L, Yen EY, et al. Consensus Treatment Plans for Severe Pediatric Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Care Res (Hoboken). 2021;doi: 10.1002/acr.24590.
Morishita, K. A., Wagner-Weiner, L., Yen, E. Y., Sivaraman, V., James, K. E., Gerstbacher, D., Szymanski, A. M., O'Neil, K. M., Cabral, D. A. (2021). Consensus Treatment Plans for Severe Pediatric Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis care & research, . https://doi.org/10.1002/acr.24590
Morishita, Kimberly A, et al. "Consensus Treatment Plans for Severe Pediatric Antineutrophil Cytoplasmic Antibody-Associated Vasculitis." Arthritis care & research vol. (2021). doi: https://doi.org/10.1002/acr.24590
Morishita KA, Wagner-Weiner L, Yen EY, Sivaraman V, James KE, Gerstbacher D, Szymanski AM, O'Neil KM, Cabral DA. Consensus Treatment Plans for Severe Pediatric Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Care Res (Hoboken). 2021 Mar 06; doi: 10.1002/acr.24590. Epub 2021 Mar 06. PMID: 33675161.
Copy
Download .nbib